NCT07633288: A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Participants With Respiratory Insufficiency Expected to be Caused by Infection With Respiratory Viruses

Sponsor: SynAct Pharma Aps. Phase: PHASE2. Conditions: Respiratory Viral Infection